Medicare is now considering the development of policy guidelines – a Medicare Coverage of Innovative Technology (MCIT) pathway – that would provide automatic coverage for Breakthrough Devices like the implantable artificial kidney. The ability to receive simultaneous FDA and Medicare approval could shave time and money needed to bring the artificial kidney to patients.
Please consider submitting a public comment
in support of the proposed MCIT rule. Medicare encourages comments that
are based in personal experience, include examples, and are backed up by
sound reasoning and evidence. Here are a few points to consider
mentioning:
• Identify yourself as a patient stakeholder and
describe your experience relying on current dialysis equipment. If you
are a Medicare patient, mention this.
• Speak to the importance of
receiving access to innovative new technologies like the implantable
artificial kidney as soon as possible.
• Convey that funding has
limited our progress and with the MCIT pathway, it is likely to catalyze
investors to support the development of the implantable artificial
kidney.
To submit a comment online, copy and paste the link below into your browser.
https://beta.regulations.gov/commenton/CMS-2020-0098-0002
Comments are due by 5pm EDT on November 2, 2020.
You can read the full text of the proposal here: https://www.federalregister.gov/…/medicare-program-medicare…
Thank you for using your voice to advocate for The Kidney Project!
[Source: Federal Register]